Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study
Fevzi Necati Avsar, Nihat Kılıcaslan, Tuncay Sahutoglu · 2026
Read Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study by Fevzi Necati Avsar, Nihat Kılıcaslan, Tuncay Sahutoglu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357671.txt.
Description
Fevzi Necati Avsar, Nihat Kılıcaslan, and Tuncay Sahutoglu compare two immune-calming drugs given to critically ill COVID patients in one hospital's intensive care unit. Both drugs were used widely against the runaway inflammation of severe disease, but head-to-head real-world evidence stayed thin. The team rebuilt each hospital day as a decision point and weighted the groups to balance patient traits before comparing deaths in hospital.
Neither drug's start was clearly tied to lower death at four weeks or across the whole stay; results sat almost exactly at no difference. Estimates for one drug stayed wide because few patients started it. Avsar and colleagues treat the finding as absence of a clear signal, not proof the drugs never help, and call for stronger designs.
Catalog record
| CREATOR | Fevzi Necati Avsar, Nihat Kılıcaslan, Tuncay Sahutoglu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35550 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |